| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50005 |
J-111 |
human |
blood |
HeLa markers* |
|
| 2 | general cells |
IFO50022 |
HL-60 |
human |
peripheral blood |
IFO strain exhibits more rapid growth compared to the original HL-60 strain. IFO strain does not respond to DMSO or TPA for differentiation unlike to original HL-60 strain. |
|
| 3 | general cells |
IFO50025 |
IM-9 |
human |
blood |
IgG-secreting B-lymphoblastic cell line. |
|
| 4 | general cells |
IFO50069 |
Alexander cells |
human |
liver |
hepatoma, HBs antigen-positive. This cell line is the same cell line as PLF/PRF/5 (other name of PLC/PRF/5). |
|
| 5 | general cells |
IFO50108 |
MG-63 |
human |
bone |
osteosarcoma |
|
| 6 | general cells |
IFO50151 |
MEG-01 |
human |
bone marrow |
Contains Ph1 chromosome. Expresses megakaryoblastic markers as GPIIb/IIIa, GPIb, FVIII-related antigens, and also CD9, CDw14. It is reported that MEG-01 cells produced platelet-like particles. Morphological changes by phorbol ester. |
|
| 7 | general cells |
IFO50152 |
TuD-1-3 |
rat |
thymus |
This cell line is a clone of TuD-1 cells (IFO 50103). |
|
| 8 | general cells |
IFO50153 |
A549 |
human |
lung |
adenocarcinoma |
|
| 9 | general cells |
IFO50299 |
Balb/c 3T3 A31-1-13 |
mouse |
embryo, whole |
fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
|
| 10 | general cells |
IFO50434 |
KALS-1 |
human |
brain |
GFAP is weakly positive. |
|
| 11 | general cells |
IFO50467 |
NMC-G1 |
human |
brain |
glioma, FGF-9-producing |
|
| 12 | general cells |
IFO50493 |
YH-13 |
human |
brain |
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-resistant |
|
| 13 | general cells |
JCRB0032 |
CCRF-SB |
human |
peripheral blood (buffy coat) |
leukemia, acute B lymphoblastic |
|
| 14 | general cells |
JCRB0117 |
B104 |
human |
blood |
Human B cell lymphoma cell line with EBNA(-). IgD and IgM were expressed on the surface of cells. |
|
| 15 | general cells |
JCRB0126.1 |
KOSC-2 cl3-43 |
human |
oral floor |
Human tumor cells derived from oral cancer at stage III. The cells were originally cross contaminated with mouse cells but the mouse cells were eliminated in the JCRB cell bank and the cl3-43 subclone ID was applied to the cell name. |
|
| 16 | general cells |
JCRB0130 |
PC-12.P3 |
rat |
adrenal medulla |
Rat pheochromo cytoma cell line derived from adrenal medulla. Use serum free DM201 media. |
|
| 17 | general cells |
JCRB0153.2 |
tsJT16 |
rat |
embryo |
Rat 3Y1 derived ts mutant cell line for cell cycle progression from G0 and G1 to S phase. |
|
| 18 | general cells |
JCRB0160 |
LI90 |
human |
liver |
Ito (fat-storing) cells, stellate-shaped mesenchymal cells that exist in the space of Disse of the liver and contain many fat droplets in cytoplasm. |
|
| 19 | general cells |
JCRB0232 |
SKG-IIIa |
human |
cervix |
cervical epidermoid carcinoma, clear cell type |
|
| 20 | general cells |
JCRB0428 |
HuO9N2 |
human |
bone |
osteosarcoma |
|
| 21 | general cells |
JCRB0533 |
TIG-112 |
human |
skin |
skin, normal diploid fibroblast |
|
| 22 | general cells |
JCRB0703 |
FM3A APRT~ |
mouse |
mammary gland |
mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse) |
|
| 23 | general cells |
JCRB0832 |
NH-6 |
human |
adrenal gland |
neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia |
|
| 24 | general cells |
JCRB1001.2 |
MS-653-G |
rat |
|
Rat fibrosarcoma cell line induced by methylcholanthrene. |
|
| 25 | general cells |
JCRB1006.4F |
OUMS-36T-4F |
human |
embryo |
Immortalized normal human cell with hTRT gene. |
|
| 26 | general cells |
JCRB1010 |
KMRC-1 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. |
|
| 27 | general cells |
JCRB1069 |
NOMO-1/ADM |
human |
peripheral blood |
leukemia, acute monocytic, adriamycin-resistant derivative of NOMO-1 |
|
| 28 | general cells |
JCRB1070 |
HSGc-C5 |
human |
floor of the mouth |
Human undifferentiated carcinoma cell line from floor of mouth (HeLa evidences observed). |
|
| 29 | general cells |
JCRB1205 |
HCSC-1 |
human |
ascites |
Human endocervical carcinoma cell line. |
|
| 30 | general cells |
JCRB1222.14 |
HGH1.37.3 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
| 31 | general cells |
JCRB1223 |
NCC-RbC-T1 |
human |
Metastasis in cerebrospinal fluid |
Human retinoblastoma cell line. The growth is very slow. |
|
| 32 | general cells |
JCRB1311 |
ZEN |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against zearalenone. |
|
| 33 | general cells |
JCRB1316.3 |
OHP138.H8.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. |
|
| 34 | general cells |
JCRB1316.4 |
OHP1E9.3.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. |
|
| 35 | general cells |
JCRB1319 |
PL-21 |
human |
white blood |
Human myeloid cell line derived from an acute promyelocytic leukemia. |
|
| 36 | general cells |
JCRB1345 |
PALL-2 |
human |
peripheral blood |
Ph1 chromosome-positive human acute lymphoblastic leukemia cell line. |
|
| 37 | general cells |
JCRB1358.11 |
SRBC-RF29-1-3 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 38 | general cells |
JCRB1449 |
KYSE1140 |
human |
esophagus |
Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 39 | general cells |
JCRB1552 |
HARA-B4 |
human |
mouse bone metastasis |
HARA cell (human lung squamouse cell carcinoma) established from bone metastasis (4 times selection) in nude mouse. |
|
| 40 | general cells |
JCRB1595 |
KYAE-2 |
human |
esophagus |
Human esophageal adenocarcinoma cell line. |
|
| 41 | general cells |
JCRB1729 |
RMG-V |
human |
ovary |
Human ovarian clear cell adenocarcinoma cell line. |
|
| 42 | general cells |
JCRB1854 |
NALM-29 |
human |
peripheral blood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)(q34;q11)-positive B-cell precursor cell line establish from acute leukemia patient. |
|
| 43 | general cells |
JCRB1956 |
HSC-39 PF |
human |
ascites |
Cell line that can be cultured only with HamF12/DMEM (protein free).
Culture start at thawing must with 2% FBS. |
|
| 44 | general cells |
JCRB2215 |
A9(Neo15) |
human chromosome-introduced |
skin |
contains human chromosome #15 (MTA with Tottori Univ. is required.)
|
|
| 45 | general cells |
JCRB4003 |
KE-43 |
human |
primary colonic carcinoma |
moderately differentiated adenocarcinoma established from primary tumor. Transition to poorly differentiated adenocarcinoma by passage.
|
|
| 46 | general cells |
JCRB4004 |
KE-43C4 |
human |
primary colonic carcinoma |
Well-differentiated adenocarcinoma obtained by cloning KE-43 |
|
| 47 | general cells |
JCRB4052 |
Daudi+ |
human |
blood |
lymphoma, Burkitt's, Deposit from the same scientist as Daudi- depositories. |
|
| 48 | general cells |
JCRB9005 |
BALB/3T3 clone A31 |
mouse |
embryo |
fibroblast, contact inhibited, (BALB/c mouse) |
|
| 49 | general cells |
JCRB9012 |
RAJI |
human |
Burkitt lymphoma |
lymphoma, Burkitt's |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.